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Abstract: A biosensor can be defined as a compact analytical device or unit incorporating a biological
or biologically derived sensitive recognition element immobilized on a physicochemical transducer
to measure one or more analytes. Microfluidic systems, on the other hand, provide throughput
processing, enhance transport for controlling the flow conditions, increase the mixing rate of different
reagents, reduce sample and reagents volume (down to nanoliter), increase sensitivity of detection,
and utilize the same platform for both sample preparation and detection. In view of these advantages,
the integration of microfluidic and biosensor technologies provides the ability to merge chemical
and biological components into a single platform and offers new opportunities for future biosensing
applications including portability, disposability, real-time detection, unprecedented accuracies, and
simultaneous analysis of different analytes in a single device. This review aims at representing
advances and achievements in the field of microfluidic-based biosensing. The review also presents
examples extracted from the literature to demonstrate the advantages of merging microfluidic and
biosensing technologies and illustrate the versatility that such integration promises in the future
biosensing for emerging areas of biological engineering, biomedical studies, point-of-care diagnostics,
environmental monitoring, and precision agriculture.
Keywords: microfluidic; biosensor; lab-on-a-chip; microfluidic-based biosensor; micro total analysis
systems (µTAS)
1. Introduction
Biosensors are considered to be powerful analytical tools and are potentially useful for a wide
range of applications ranging from drug discovery, to medical diagnostics, to food safety, to agricultural
and environmental monitoring, and to security and defense [1]. A biosensor can be defined as an
analytical device [1,2] that combines a biological sensitive recognition element [3] (such as antibodies,
nucleic acids, enzymes, or aptamers) immobilized on a physicochemical transducer, and connected to a
detector to identify the presence of one or more specific analytes [4], their concentrations, and kinetics
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in a sample. The specificity and selectivity of the biosensor is determined by the catalytic or affinity
properties of the biological recognition element. The signal originating from the interaction between
the analyte of interest and the biological recognition element is then transformed by a transducer to an
optical or electrical readout [5,6]. Biosensors are more favorable, reliable, accurate, cost effective, and
easy to use compared to other conventional lab-based detection techniques [7] due to their portability,
reusability, real-time response, and high specificity and selectivity.
Microfluidics is considered to be a multidisciplinary technology that links several different
sciences including chemistry, biochemistry, engineering, physics, micro-technology, nano-technology
and biotechnology [8]. The large surface-to-volume ratio enables portability of microfluidic devices
which is important for on-site testing. There are three classes of microfluidics: (i) continuous-flow;
(ii) droplet-based; and (iii) digital microfluidics. Continuous microfluidic devices consist of
permanently etched microchannels and peripheral devices (such as micropumps and microvalves)
used to manipulate a stream of fluid in these devices [9]. Droplet-based microfluidic systems are based
on creating droplets in micro-channels using two (or more) immiscible fluids (mostly) at a T-junction.
Digital microfluidic systems, however, are fundamentally different as they provide motion and control
of discrete droplets on an array of planar electrostatically-actuated electrodes.
In this paper, examples from the literature are presented to demonstrate the advantages of merging
microfluidic and biosensor technology and illustrate the versatility that such a merging promises
in the future biosensing for numerous areas of biological engineering, environmental monitoring,
biomedical applications, agricultural monitoring, industrial monitoring, and point-of-care diagnostics.
We have divided this review into three sections: (i) different types of biosensors (categorized based
on the biological recognition elements and transducers); (ii) different types of microfluidic platforms
with their advantages and disadvantages; and (iii) examples of integrated biosensors in different
microfluidic platforms.
2. Biosensors
In the past two decades, there has been a significant growth and interest in biosensor technology
and research [10]. According to the International Union of Pure and Applied Chemistry (IUPAC) [11], a
biosensor is defined as “an independently integrated receptor transducer device, which is capable of providing
selective quantitative or semi-quantitative analytical information using a biological recognition element”. This
makes biosensing technology a powerful analytical tool capable of detecting biological or chemical
molecules using electrical [12], optical [13], or mass change readout protocols [14]. Figure 1 shows a
schematic of the different parts in a biosensor. The two important parts that distinguish the biosensors
are the type of biological recognition sensing element and the transducers.
2.1. Biosensors Categorized Based on the Type of Biological Recognition Element and Immobilization Techniques
The biological recognition sensing element dictates the selectivity and specificity that allows the
biosensor to respond to a specific target or group of analytes, decreasing the possibility of interference
with undesired substances [15]. The selection of the biological recognition element depends on the
target of interest (e.g., antibodies and aptamers are more suitable for the detection of bacteria or
pathogens; whereas enzymes are more suitable for catalytic reactions).
In general, the biological recognition elements are immobilized using different methods such as
adsorption, covalent binding, entrapment, and membrane confinement. Figure 2 shows the schematic
of some of the most common immobilization methods. In general, immobilization with covalent
bonding is the most common and preferable method due to stability and irreversibility which prevents
leakage of the biological elements from the support surface [16,17].
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Figure 2. Schematic of the most common and main immobilization methods. 
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For example, glucose oxidase, one of the most widely-used biosensors, is an oxidoreductase enzyme that 
transfers electrons from glucose to molecular oxygen. The glucose biosensor, first described by Clark 
and Lyons in 1962 [19], uses immobilized glucose oxidase to determine glucose concentrations in  
bodily fluids. 
One of the advantages of using enzymes as a biological recognition element in biosensor technology 
is that they are highly selective to a specific substrate or a class of substrates. The second advantage is 
that during catalytic turnover, enzymes can produce ions, protons, heat, light, and/or electrons which are 
all measurable parameters [2]. 
2.1.2. Antibody-Based Biosensor 
Recently, antibodies (Abs) have been applied widely [20] as recognition elements in biosensors in 
the most rapid detection systems [21,22]. The use of antibodies as recognition elements has attracted 
attention [22] especially after establishing the monoclonal antibody (Mab) technology by Kohler and 
Milstein [23]. One of the major advantages of the antibody-based biosensor is that the immunogen  
(i.e., analyte of interest) does not need to be purified prior to detection [21,24]. Recently, recombinant 
antibodies have been successfully created by genetically modified antigen binding sites (Fab fragment) 
of common antibodies [25]. 
2.1.3. Aptamer-Based Biosensor 
In the past three decades, research in aptamers have grown dramatically and become one of the  
most important biological recognition elements competing with antibodies in the development of 
biosensors [26,27]. Aptamers are defined as amino acid polymers or a single-stranded nucleic acid that 
have a high selectivity, specificity and affinity towards a target analyte ranging from small molecules to 
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ranging from 105 to 1017 gre ter an tha of the uncatalyzed reactions [18]. Enzymes that act as
biosensors typically catalyze oxidation-reduction (or redox) reactions. The turnover of these enzymes
can be monitored by a variety of electrochemical methods, which makes them ideal biosensors. For
example, glucose oxidase, one of the most widely-used biosensors, is an oxidoreductase enzyme that
transfers electrons from glucose to molecular oxygen. The glucose biosensor, first described by Clark
and Lyons in 1962 [19], uses immobilized glucose oxidase to determine glucose concentrations in
bodily fluids.
One of the advantages of using enzymes as a biological recognition element in biosensor
technology is that they are highly selective to a specific substrate or a class of substrates. The second
advantage is that during catalytic turnover, enzymes can produce ions, protons, heat, light, and/or
electrons which are all measurable parameters [2].
2.1.2. Antibody-Based Biosensor
Recently, ntibodies (Abs) have been applied widely [20] as recognition elements in biosensors in
the most rapid detection systems [21,22]. The use of antibodies as recognition elements has attracted
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attention [22] especially after establishing the monoclonal antibody (Mab) technology by Kohler and
Milstein [23]. One of the major advantages of the antibody-based biosensor is that the immunogen
(i.e., analyte of interest) does not need to be purified prior to detection [21,24]. Recently, recombinant
antibodies have been successfully created by genetically modified antigen binding sites (Fab fragment)
of common antibodies [25].
2.1.3. Aptamer-Based Biosensor
In the past three decades, research in aptamers have grown dramatically and become one of the
most important biological recognition elements competing with antibodies in the development of
biosensors [26,27]. Aptamers are defined as amino acid polymers or a single-stranded nucleic acid that
have a high selectivity, specificity and affinity towards a target analyte ranging from small molecules to
whole cells [26,28]. Generally, an in vitro selection method called Systematic of Ligands by Exponential
enrichment (SELEX) [28] is used to isolate aptamers from large combinatorial libraries containing
approximately 1015 different sequences [29].
Aptamers have the ability to bind to their specific ligands with dissociation constants in the
micromolar to picomolar range [20], and can be selected for a wide range of analytes such as pathogens,
toxins [30], proteins [30,31], and whole cells [32]. Some of the advantages of aptamers as biological
recognition elements over antibodies include the aptamer’s long-term stability [33], their inexpensive
and rapid synthesis [33,34], and their ability to be modified with labels with little effect on their binding
site performance, stability, or binding characteristics [33,35]. In any case of these biological recognition
elements mentioned above, they are commonly immobilized onto a solid support so that it cannot
be readily removed but can still react freely with its substrate. In essence, the main advantages of an
immobilized biological recognition element include easy separation from the reaction mixture and the
ability to control reaction times and minimize the biological recognition elements lost in the reaction
mixture [16].
2.2. Biosensors Categorized Based on the Type of Transducers
Biosensors can be classified into several different kinds according to the kind of transducer
used. The transducer transforms the biomolecule-analyte interaction into a measurable optical [24] or
electrical signal [36]. The selection of the transducer depends on the nature of the physicochemical
change of the reaction that takes place at the sensing layer generated [3]. Both transducers and
biological recognition elements are important for enhancing the sensitivity and detection limit of the
biosensor [36].
A wide range of transducers has been developed and employed; however, the most popular
methods are: (a) electrochemical; (b) optical (including colorimetric); (c) piezoelectric; and
(d) magnetic [37]. Table 1 summarizes different sensing techniques with their advantages and
disadvantages for the detection of a range of analytes using the most common transducers.
2.2.1. Electrochemical-Based Biosensors
Recently, most of the biosensors used in the literature are mainly based on electrochemical
detection [38,39]. It has been suggested that electrochemical biosensors will be responsible for a big
improvement in the future of genetic testing [40]. High sensitivity, low power requirements, low
cost, and relatively simple instrumentation [40,41] make electrochemical detection methods highly
compatible for the development of biosensors. In general, there are three categories of electrochemical
sensors that can be used to detect any changes in the electrochemical responses occurring during the
reaction. These categories are defined based on the detected parameter which include amperometric
(current), potentiometric (potential), and impedance (impedimetric) [42].
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Table 1. Different examples of sensing techniques with their advantages and disadvantages.
Transducer Technique Advantages Disadvantages
Electrochemical
Amperometric [43,44] Simplicity, miniaturization,low cost
Need redox elements to enhance the
current production; time consuming;





analysis on different analytes
Sensitive to the surrounding
environment; time consuming;
sensitive to temperature
Impedimetric [47,48] Simplicity and real-timedetection
Sensitive to the surrounding
environment; bulky devices required;
require theoretical stimulation for
data analysis
Optical Surface plasmonresonance (SPR) [49,50]
Real-time detection; reliable,
high sensitivity
Sensitive to the surrounding
environment; surface modification as




Real-time detection; ability to
detect more than one analyte
with high sensitivity
Sensitive to the surrounding
environment; sensitive to











Optical biosensing is a vital analytic and detection technique, which has a wider application in the
field of medical diagnostics [55,56] , food analysis [57,58] , environmental applications [59,60], drug
discovery [61,62], and security and defense [63,64]. Optical techniques are used to detect the optical
change due to the interaction between the target of interest and the biological recognition element
(immobilized on the optical sensing layer), and transform the signal to a quantifiable measurement
which is correlated to the analyte concentration in the sample [65]. They have many advantages,
making optical detection one of the leading detection methods in the biosensor field. These advantages
include low detection limit, versatility, label-free, non-destructive, and their ability to detect a wide
variety of analytes or multiple analytes at the same time with fast signal monitoring and analysis [66].
Optical biosensors use either direct detection of the analyte (such as UV absorption [67], planar optical
waveguide [68], fiber optics [69], surface-enhanced Raman Scattering (SERS) [70] and surface plasmon
resonance (SPR) [71]), or indirect detection through optically labelled probes (such as fluorescence and
chemiluminescence [72]).
2.2.3. Colorimetric Biosensors
Most of the colorimetric detection techniques involve monitoring the formed colored products
as a result from the reaction between the analyte of interest and biological recognition element. The
colored product, which can be identified by a naked eye or the use of an optical sensing instrument,
is proportional to the analyte concentration. These types of detection are classified as a label-free
detection method [73].
2.2.4. Mass Biosensors
One of the unique signal transduction methods in the configuration of biosensor is the fast mass
transformation occurring due to the interaction between the analyte and the immobilized biological
recognition element. When the mass of the crystal increases due to specific reaction or binding of an
analyte to biological layer immobilized on the surface, a change in the oscillation frequency of the
crystal occurs, identifying the concentration of the analyte [74]. This type of biosensors is very sensitive
and can measure even small changes of the interacting molecules weight on the crystal surface [75].
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2.2.5. Magnetic Sensors
The use of magnetic sensing that relies on the use of micro/nanoparticles labelling has increased in
recent years. Bio-molecules have virtually no magnetic properties; therefore, the addition of magnetic
micro/nanobeads to bio-molecular samples could be used to separate, and quantify a known analyte
within a given sample [76]. A number of magnetic platforms have been used to detect a number of
disease targets such as proteins [77], cancer cells [78], enzymes and pathogens.
3. Microfluidics
Numerous microfluidic devices have been developed for different biological and chemical
applications [79]. Conventional microfluidic systems are based on the continuous flow regimes in
micron-sized channels (Figure 3a). These micro-channels are fabricated mainly using soft-lithography
methods [80]. To reduce the sample consumption, and also create isolated reaction sites, droplet-based
microfluidic systems have been developed [81]. The first generation of the droplet-based microfluidic
systems utilized the continuous stream of two or more fluid mainly intersected at a T-junction to create
discrete droplets which are isolated from each other using an immiscible fluid (Figure 3b) [82]. To
further decrease the volume consumption, a new generation of droplet-based microfluidic systems,
called digital microfluidic (DMF), was introduced in early 2000s [83]. Rather than having continuous
flow of droplets in the micro-channels, DMF systems create droplets on an array of electrostatically
actuated electrodes (Figure 3c). The most commonly used actuation mechanism for moving the
droplets on the array of electrodes is electrowetting-on-dielectric (EWOD) technique which is based on
changing the interfacial properties of the liquid using an electric field [84]. EWOD method provides
higher localization compared to the other methods. In addition to lower power consumption, the
EWOD-based DMF systems have many advantages over the continuous microfluidic systems such as
lower power consumption and scalability [85]. These intrinsic characteristic of these systems makes
them a very suitable choice for implementing additional sensing modules. In particular, in recent years,
these systems have been used for numerous biosensing applications as they allow for high throughput
parallel processing of multiple samples on the same chip. Table 2 summarizes the operating and
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Table 2. The comparison between the three types of microfluidics.
Continuous-Flow Microfluidics Droplet-Based Microfluidics Digital Microfluidics
Operating Method Motion of continuous fluid inmicro-channels
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Fabrication and designing of microfluidics platforms for biosensors need careful addressing and
considerations such as: dimensions, materials, and the method used for fabrication to improve the
biocompatibility and wettability of the fabricated device [86]. Glass and silicon are well known to be
the most common materials used in fabricating and designing microfluidic platforms. The low cost of
polymer materials and their manufacturing has made them one of the popular materials used in the
fabrication and designing of microfluidic devices recently [87]. The excellent chemical, physical and
mechanical properties of polymers (e.g., polymethylmethacrylate (PMMA), and polydimethylsiloxane
(PDMS)) have increased the biocompatibility of using them in the fabrication and designing of
microfluidic devices [88]. Examples of some of the different fabrication methods and materials
used to fabricate microfluidic devices for biosensing applications are summarized in Table 3.
Table 3. Examples of some of the different fabrication methods and materials used to fabricate
microfluidic devices for biosensing applications.
Fabrication Method Fabrication Material Advantages Disadvantages
Photolithography [89] PDMS
Portability
Low throughputCost-effective and high automation
High sensitivity










4. Integration of Microfluidics with Biosensor Technology
Recently, a significant demand and effort in merging biosensors into lab-on-chip (LOC) technology
using microfluidics systems has been demonstrated [92,93] which add numerous benefits to the
biosensor technology [94]. The integration of biosensors with microfluidic systems offers an integrated
and miniaturized alternative to the traditional repetitive laboratory methods [95,96], as it offers
significant reduction in sample, reagent, energy consumption [97,98], and waste production [99].
Moreover, the microfluidic biosensors can decrease the cost, and increase the specificity and detection
sensitivity limit compared to the regular detection methods.
Due to the small size of micro-systems, a single microfluidic biosensor can perform
full analysis [100] including continuous sampling, sample separation and mixing [101], and
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pre-concentration and treatment [102]. Furthermore, these microfluidic biosensors offer
enhanced analytical performance, high throughput, real-time detection, fast reaction rates and
portability [103,104], making detection adaptable to point of care (POC) applications [105]. Overall,
the integration of biosensors with the microfluidic systems creates a powerful analytical tool that
will be an advanced step towards the home-testing approach which will benefit both developing and
developed countries.
In the next section, examples of microfluidics based biosensors will be explained based on the
different kinds of microfluidics and the biological recognition element used as the sensing layer in the
biosensor. Table 4 shows a comparison between some of the common biological recognition elements
used in microfluidic systems for biosensing applications with their advantages and disadvantages.




High sensitivity Possibility of losing their activity upon
immobilizationHigh selectivity towards their targets
Suitable for oxidation reduction
reactions
Most suitable for small analytes, e.g.,
glucose, urea and lactate
Antibodies [106,107]
Rapid analysis for direct
immunoassays
Requiring labeling for indirect immune
assays which can result in the increase
cost and time required for analysis
Suitable for bioaffinity interaction e.g.,
antibody-antigen interaction
Not suitable for detection of small targets
using direct and sandwich immunoassays
Suitable for the detection of large
targets e.g., bacteria and pathogens
Not suitable for oxidation reduction
reactions
Aptamers [108,109]
Highly sensitive and selective Higher toxicity than antibodies
Suitable for the detection of a wide
range of analytes Faster excretion due to their small size
Long-term stability, inexpensive and
rapid synthesis Weaker binding to analytes
Flexibility to be modified with labels
without losing their performance or
binding properties
4.1. Continuous Microfluidic-Based Biosensor
In the last two decades, the continuous microfluidic system has improved. The huge advancement
in microfluidic research has increased the study of biological systems ranging from molecules to
small multicellular organisms. Microfluidics has added a great ability to sensing devises over
conventional methods as it can sense small volumes of analytes, resulting in reducing reagent and
energy consumption, less waste, reducing the cost and the integration of chemical and biological
process on a single platform [104]. Recently, continuous microfluidic has been widely used in unique
different applications such as: (a) chemical and system biology [106,107]; (b) biological screening
and drug discovery [96]; (c) clinical diagnostic [107]; (d) point-of-care devices for environmental
and (e) biomedical applications [109]. In the following subsections, examples of continuous
microfluidics-based biosensors using different biological recognition element are illustrated.
4.1.1. Enzyme-Based
A few examples on the application of the biosensor technology and its integration with the
continuous microfluidic platforms have been reported and demonstrated in the past. For instance,
an example for the integration of bienzyme functionalized nanocomposite with a microfluidic
biosensor was demonstrated by Ali et al. [110] (see Figure 4). In this work, they have illustrated
successful fabrication and integration of a novel microfluidics biochip using a multi-walled carbon
nanotubes (MWCNTs) and nickel oxide nanoparticles (nNiO). Photolithographic technique was used
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to integrate the nanocomposite with the polydimethylsiloxane (PDMS) microchannels. The surface
of the integrated nanocomposite-microchannels was functionalized with two enzymes including
cholesterol oxidase (ChOx) and cholesterol esterase (ChEt). The final structure was then characterized
using X-ray photoelectron spectroscopy (XPS) and scanning electron microscopy techniques. The
fabricated chip was used to measure the chronoamperometric change in the presence of different
concentrations of cholesterol oleate (0.25–12.93 mM). The results showed a linear relation between the
chronoamperometric change and the cholesterol oleate concentrations. The novel integrated system
provided high reproducibility, selectivity and excellent sensitivity of 2.2 mA/mM/cm2.
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Regular self-assembled monolayer (SAM) was used to immobilize the anti-rabbit IgG on the modified 
gold surface. They achieved high specificity and selectivity by delivering and accurate amounts of IgG 
solution to the detection are using micropumps/valves. The results showed that the fabricated 
microfluidic platform, which used SPR phase imaging successfully detected the presence of only IgG in 
the samples. The novel integrated system provided a high selectivity and excellent sensitivity with a 
detection limit of 1 × 10−4 mg/mL (0.67 nM) which provide a highly sensitive and selective, rapid and 
low-cost sensing platform for the detection of biomedical samples and protein-protein interactions. 
Figure 4. Schematic of the bienzyme functionalized nanocomposite microfluidic-based biosensor
developed for the detection of cholesterol (Reprinted with permission from Scientific Reports) [110].
4.1.2. Antibody-Based
An example for the integration of a continuous microfluidic device and biosensor using antibodies
as the iologic l recognition element is demonstrated by Lee et al. [111] for the detection of breast cancer
using the SPRi method. They have managed to develop an automated lab-on-a-chip microfluidic
biosensor with multiple channels for the detection of a microarray s mples (see Figure 5). Since
SPR is a temperature dependent technique, they used a temperature control unit consisting of micro-
heaters and temperature sensors to avoid temperature change and variation in the sensing area during
the experiment. Regular self-assembled monolayer (SAM) was used to immobilize the anti-rabbit
IgG on the odified gold surface. They achieved high specificit and selectivity by delivering and
accurate amou ts of IgG solution to the detection are using micropumps/valves. The results showed
that the fabricated microfluidic platform, which used SPR phase imaging successfully detected the
presence of only IgG in the samples. The novel integrated system provided a high selectivity and
excellent sensitivity with a detection limit of 1 ˆ 10´4 mg/mL (0.67 nM) which provide a highly
ensitive and selective, rapid and low- ost sensing platform for the d tection of biomedic l samples
and protein-protein interactions.
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Figure 5. Illustration of 2D surface plasmon resonance (SPR) imaging integrated with a 
microfluidic platform for the detection of microarray immunoassay samples (Reprinted with 
permission from Elsevier) [111].  
4.1.3. Aptamer-Based 
There are several advantages that make aptamers a preferable biological recognition element over 
antibodies. These advantages include simplicity in the structure of aptamers and the ability to design 
them in a way to yield an optical or electrical signal (upon binding with the target) without the need for 
secondary labeling and washing steps, reducing the cost and time [108,112]. An excellent example for 
an on-chip aptamer-based sensor was developed by Zhou et al. [113] for the continuous detection of 
living cells (see Figure 6). Their microdevice was fabricated on glass substrate with gold electrodes and 
two polydimetylsiloxane (PDMS) layers as shown in Figure 6a. The two PDMS layers were designed 
so that the first layer contains microchannels and semi-circular microcups, and the second layer was 
mainly used for pneumatic control. The microcups were raised during the protein secretion by cells 
which increased protein diffusion toward the sensing area. The microcups are then lowered during the 
physical separation of cells from the sensing electrode area (see Figure 6b). Square wave voltammetry 
(SWV) measurements were used to confirm the interaction between the cell-secreted protein (IFN-γ) 
and the specific aptamer. The results showed a decrease in the redox signal which is proportional to the 
analyte concentration in the sample. The novel integrated system provided a regenerative aptamer 
microfluidic-based biosensor for the continuous monitoring of proteins secreted by cells with a detection 
limit of (5 ng·mL−1). 
Figure 5. Illustration of 2D surface plasmon resonance (SPR) imaging integrated with a microfluidic
platform for the detection of microarray immunoassay samples (Reprinted with permission from
Elsevier) [111].
4.1.3. Aptamer-Based
There are several advantages that make aptamers a preferable biological recognition element over
antibodies. These advantages include simplicity in the structure of aptamers and the ability to design
them in a way to yiel an optical or electrical signal (upon binding with the target) without the n ed
for secondary labeling and washing steps, reducing the cost and time [108,112]. An excellent example
for an on-chip aptamer-based sensor was developed by Zhou et al. [113] for the continuous detection of
living cells (see Figure 6). Their microdevice was fabricated on glass substrate with gold electrodes and
two polydimetylsiloxane (PDMS) layers as shown in Figure 6a. The two PDMS layers were designed
so that the first layer contains microchannels and semi-circ lar microcups, and the second layer was
mainly used for pneumatic control. The microcups were raised during the protein secretion by cells
which increased protein diffusion toward the sensing area. The microcups are then lowered during the
physical separation of cells from the sensing electrode area (see Figure 6b). Square wave voltammetry
(SWV) measurements were used to confirm the interaction between the cell-secreted protein (IFN-γ)
and the specific aptamer. The results showed a decreas in the redox signal which is proportional
to the analyte concentration in the sample. The novel integrated system provided a regenerative
aptamer microfluidic-based biosensor for the continuous monitoring of proteins secreted by cells with
a detection limit of (5 ng¨mL´1).
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Figure 6. (a) Schematic of the whole layout of the aptamer microfluidic-based biosensor; 
(b) the steps taken for the development of the biosensor and the principle of detection of the 
sensing of cytokine. The regeneration of cytokine is explained in the lower panel by showing 
the square wave signals during sensing (left) and regeneration steps (right) (Reprinted with 
permission from Royal Society of Chemistry) [113]. 
4.2. Droplet Microfluidic-Based Biosensor 
Droplet-based microfluidics is one of the most significant systems to be integrated with the biosensor 
technology. Recently, droplet-based microfluidics has extensively been used as a new platform for a 
wide range of applications including environmental, biomedical, security and defense with a better 
portability, and low energy [114]. In the following subsections, examples of droplet microfluidics-based 
biosensors using different biological recognition element are illustrated. 
4.2.1. Enzyme-Based 
An example of a droplet-based microfluidic electrochemical sensor using Pt-black microelectrode 
and enzymes for the detection of glucose was demonstrated by Gu et al. [115] (see Figure 7). 
Electrochemical impedance spectroscopy (EIS) and cyclic voltammetry (CV) were used to measure the 
change in the electrochemical current due to the oxidation of β-D-glucose, resulting in the byproduct of 
H2O2. The novel integrated microfluidic based electrochemical biosensor system provides a highly 
sensitive and low-cost glucose sensor with linear response up to 43.5 mM. 
4.2.2. Antibody-Based 
A novel all-in-one droplet-based microfluidic biosensor (Scandrop) has recently been developed by 
Golberg et al. [116] using magnetic beads conjugated with antibodies as the biological recognition 
element which are specific for the capture and the detection of bacteria E. coli in drinking water. First 
anti-E. coli antibodies conjugated magnetic beads were used to selectively capture and isolate E. coli from 
the contaminated water. The isolated bacteria were then co-encapsulated with fluorescently-labeled anti-E. 
Figure 6. (a) Schematic of the whole layout of the aptamer microfluidic-based biosensor; (b) the steps
taken for the development of the biosensor and the principle of detection of the sensing of cytokine.
The regeneration of cytokine is explained in the lower panel by showing the square wave signals
during sensing (l ft) and r neration steps (right) (Reprinted with permission from Royal Society of
Chemistry) [113].
4.2. Droplet Microfluidic-Based Biosensor
Droplet-based microfluidics is one of the most significant systems to be integrated with the
biosensor technology. Recently, droplet-based microfluidics has extensively been used as a new
platform for a wide range of applications including environmental, biomedical, security and defense
with a better portability, and low energy [114]. In the following subsections, examples of droplet
microfluidics-based biosensors using different biological recognition element are illustrated.
4.2.1. Enzyme-Based
An example of a droplet-based microfluidic electrochemical sensor using Pt-black microelectrode
and enzymes for the detection of glucose was demonstrated by Gu et al. [115] (see Figure 7).
Electrochemical impedance spectroscopy (EIS) and cyclic voltammetry (CV) were used to measure the
change in the electrochemical current due to the oxidation of β-D-glucose, resulting in the byproduct
of H2O2. The novel integrated microfluidic based electrochemical biosensor system provides a highly
sensitive and low-cost glucose sensor with linear response up to 43.5 mM.
4.2.2. Antibody-Based
A novel all-in-one droplet-based microfluidic biosensor (Scandrop) has recently been developed
by Golberg et al. [116] using magnetic beads conjugated with antibodies as the biological recognition
element which are specific for the capture and the detection of bacteria E. coli in drinking water.
First anti-E. coli antibodies conjugated magnetic beads were used to selectively capture and
isolate E. coli from the contaminated water. The isolated bacteria were then co-encapsulated
with fluorescently-labeled anti-E. coli antibodies in pico-liter droplets and were analyzed using an
automated fluorescence microscope. The detection process required only 8 h of sample collection,
pre-concentration, ca turing and detection (see Figure 8). The system shown a great potential
towards the development of droplet-based microfluidic biosensor for monitoring of pathogens
in drinking water compared to the conventional methods requiring 2–4 days for the detection
of pathogens.
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Figure 8. Schematic of the droplet-based electrochemical biosensor for the detection of E. coli using
magnetic beads conjugated with antibodies as the biological recognition element.
4.2.3. Aptamer-Based
Recently, a “finger-powered” bead-in-droplet microfluidic system was developed using
aptamer-beacons to detect the inflammatory cytokine interferon gamma. Droplets containing
aptamer-functionalized microbeads were generated by a finger push-and-release sequence. When
interferon gamma was present within the droplets, the fluorescence intensity of the aptamer-beacons
was detectable [117]. In another example, the detection of a membrane protein PTK7 on single
living cells was demonstrated using aptamers in droplet-based microfluidics. The droplets served
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as independent microreactors where a fluorescence amplification reaction was taken place between
the aptamer and a nicking enzyme, allowing for very sensitive, high throughput detection [118]
(see Figure 9).
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Figure 9. (A) Schematic of the sensitive detection of the membrane protein on single living 
cells using aptamer and nicking enzyme as the biological sensing element;  
(B) Schematic of the whole droplet-based microfluidic system (Reprinted with permission 
from American Chemical Society) [118].  
4.3. Digital Microfluidic-Based Biosensor 
Digital microfluidics (DMF), as another approach used for the manipulation of liquid samples as 
microdroplets, has offered reconfigurability and flexibility and limited contamination during sample 
preparation and analysis. This type of platform is compatible with a wide range of detection methods 
Figure 9. (A) Schematic of the sensitive detection of the membrane protein on single living cells
using aptamer and nicking enzyme as the biological sensing element; (B) Schematic of the whole
droplet-based microfluidic system (Reprinted with permission from American Chemical Society) [118].
4.3. Digital Microfluidic-Based Biosensor
Digital microfluidics (DMF), as another approach used for the manipulation of liquid samples as
microdroplets, has offered reconfigurability and flexibility and limited contamination during sample
preparation and analysis. This type of platform is compatible with a wide range of detection methods
(such as optical and electrochemical detection [83]) and eliminates the use of c nventional pumps,
valves or channels, unlike the continuous microfluidics [119]. Integrating of biosensors into the DMF
platforms has enhanced the functionality of different fluidic operations (e.g., transport, mixing, splitting
and separation) developed for DMF platforms so far [120,121] . In the following subsections, examples
of digital microfluidics-based biosensors using different biological recognition element are illustrated.
4.3.1. Enzyme-Based
The integration of optical absorbance measurements system with digital microfluidics for the
detection of body metabolites using glucose oxidase as the biological recognition element has been
reported by Srinivasan et al. [122] (see Figure 10). The developed devise was also tested towards the
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detection of glucose in the droplet sample using a colorimetric enzyme-kinetic assay. For this purpose,
they integrated a colorimetric enzyme-kinetic assay into the digital microfluidic platform, and hence
developed an optical DMF-based biosensor for the rapid detection of glucose in less than 40 s with a
linear response in the range of 25 mg/dl to 300 mg/dl, with less than 5% linearity deviation from the
high limit. The developed system was successfully tested for the detection of glutamate, pyruvate,
and lactate.
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Figure 10. Schematic of the digital microfluidic-based optical biosensor for the rapid 
detection of glucose in a droplet sample. 
4.3.2. Antibody-Based 
The integration of field effect transistor (FET) biosensor into the digital microfluidic technology using 
antibodies as the biological recognition element was demonstrated by Choi et al. [123]. They developed 
a new digital microfluidic FET-based biosensor for the real time detection of avian influenza antibody 
(anti-AI). The device works based on the measurement of the current drained from the FET biosensor 
without the need for using labels (see Figure 11). The electrowetting-on-dielectric method (EWOD) was 
used to deliver the droplet containing the analyte anti-AI from the inlet to the sensing area. The results 
Figure 10. Schematic of the digital microfluidic-based optical biosensor for the rapid detection of
glucose in a droplet sample.
4.3.2. Antibody-Based
The integration of field effect transistor (FET) biosensor into the digital microfluidic technology
using antibodies as the biological recognition element was demonstrated by Choi et al. [123]. They
developed a new digital microfluidic FET-based biosensor for the real time detection of avian influenza
antibody (anti-AI). The device works based on the measurement of the current drained from the FET
biosensor without the need for using lab ls (see Figure 11). The elec rowetting-on-dielectric method
(EWOD) was used to deliver the droplet containing the analyte anti-AI from the inlet to the sensing
area. The results showed a decrease in the drain current upon the binding of the target antigen and
the specific anti-AI antibodies. The system has shown a great potential towards the detection of
anti-AI with a detection limit of 0.5 pg¨mL´1 (6.67 fM).The integration of digital microfluidics with the
FET-based sensor using antibodies as the biological recognition element has shown a great potential
towards biomolecules transportation and detection without the need of pumps, bulky transduces or
small fluidic channels.
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IgE from the magnetic beads. The assay had a limit of detection (LOD) of 150 nM of IgE [121]. 
5. Conclusions  
Standard methods for identification and detection of specific targets are expensive, time consuming, 
and suffer from the lack of portability. The integration of microfluidics and biosensors provides a 
powerful tool to replace the bulky traditional instruments with the ability to merge chemical and 
biological components into a single platform. Biosensors are considered to be a powerful analytical tools 
and are potentially useful for a wide range of applications ranging from drug discovery, to medical 
diagnostics, to food safety, to agricultural and environmental monitoring, and to security and defense [1]. 
A biosensor can be defined as an analytical device [1,2] that combines a biological sensitive recognition 
element [3] immobilized on a physicochemical transducer connected to a detector to identify the 
Figure 11. Schematics of the developed field effect transistor (FET) digital microfluidic biosensor: (a) a
top-view; (b) a side-view; (c) an enlarged view of the FET digital microfluidic biosensor and (d) a
cross-sectional view of the FET digital microfluidic biosensor (Reprinted with permission from Royal
Society of Chemistry) [123].
4.3.3. Aptamer-Based
Aptamer have been used in conjunction with antibodies in digital microfluidic biosensors. A
droplet with fluorescently labeled IgE aptamer and magnetic nanoparticles coated with anti IgE was
merged with a second droplet containing unlabeled IgE. The mixture was brought to a permanent
magnet to hold the magnetic beads. The droplets of a washing buffer were passed over the beads to
remove unbound IgE from the magnetic beads. The assay had a limit of detection (LOD) of 150 nM of
IgE [121].
5. Conclusions
Standard methods for identification and detection of specific targets are expensive, time
consuming, and suffer from the lack of portability. The integration of microfluidics and biosensors
provides a powerful tool to replace the bulky traditional instruments with the ability to merge chemical
and biological components into a single platform. Biosensors are considered to be a powerful analytical
tools and are potentially useful for a wide range of applications ranging from drug discovery, to
medical diagnostics, to food safety, to agricultural and environmental monitoring, and to security
and defense [1]. A biosensor can be defined as an analytical device [1,2] that combines a biological
sensitive recognition element [3] immobilized on a physicochemical transducer connected to a detector
to identify the presence of one or more specific analytes [4], their concentrations and kinetics in a
sample. The specificity and selectivity of the biosensor is mainly based on the affinity properties of
the biological recognition element. The signal originating from the interaction between the analyte
of interest and the biological recognition elem nt is then ransformed by a transduc r to an optical
or electrical readout [5,6]. Microfluidics technology, on the other hand, provides great ability to
perform and analyze complex operations including chemical and system biology [106,107], biological
screening and drug discovery [61,62], clinical diagnostic [107], detection of different toxins [124],
and inexpensive point-of-care devices for environmental, biomedical applications in developing
and developed countries [109]. The advances made in the soft lithography techniques have even
made the design of new microfluidic platforms much easier and faster. The use of microfluidic
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devices has provided an opportunity to perform laboratory processes [95,96] using small volumes
of analytes, resulting in reduction of reagents, lower energy consumption [97], real-time detection,
and simultaneous analysis of different and multiple analytes on a single platform (especially required
for point-of-care testing) [98,99]. This paper presents a review of the advances and successes made in
the fields of biosensors and microfluidics, and especially microfluidic-based biosensors in different
applications. Different types of biosensors (with different types of biological recognition elements
including enzymes, antibodies, and aptamers) and microfluidic systems (i.e., continuous, droplet-based,
and digital microfluidics) were presented. The most important part of this review includes examples
of integrated biosensors into microfluidic platforms, illustrating the versatility of such as integration
for emerging areas of biological engineering, biomedical studies, point-of-care diagnostics, and
environmental monitoring.
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